# Centrally Confined 8Gy/1f to Tumor Core Followed by Concurrent Chemoradiotherapy for Unresectable Stage III NSCLC

> **NCT07523464** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Anhui Provincial Hospital** · enrollment: 24 (estimated)

## Conditions studied

- Locally-Advanced Non-Small Cell Lung Cancer
- Radiotherapy

## Interventions

- **RADIATION:** Centrally Confined 8 Gy/1 Fraction Immune-Priming Radiotherapy to the Tumor Core Followed by Definitive Concurrent Chemoradiotherapy

## Key facts

- **NCT ID:** NCT07523464
- **Lead sponsor:** Anhui Provincial Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2027-06-30
- **Final completion:** 2028-12-30
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07523464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07523464, "Centrally Confined 8Gy/1f to Tumor Core Followed by Concurrent Chemoradiotherapy for Unresectable Stage III NSCLC". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07523464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*